CAUSEY CHRISTOPHER bought UTHR
March 30, 2026 · Form 4 insider transaction
CAUSEY CHRISTOPHER bought 1,300 shares of United Therapeutics Corporation at $119.76 per share, a transaction worth $155.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,300
Price
$119.76
Total value
$155.7K
InsiderCAUSEY CHRISTOPHER
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 30, 2026
Filing dateMarch 31, 2026
Shares owned after5,490
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.